PRLX-93936 HCL
PRLX-93936 HCL, an erastin analog, exhibits synergistic anti-cancer activity with cisplatin in non-small cell lung cancer (NSCLC) cell lines. This compound is a research tool for studying ferroptosis and combination therapies in oncology, applicable in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1094210-96-4
Product Name Alternative
Ferroptosis, Reactive Oxygen Species, ReactiveOxygenSpecies, PRLX-93936 HCL, PRLX-93936 hcl (903499-49-0 Free base), PRLX93936 HCL, PRLX 93936 HCL
Field of Research
Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
98.40% (May vary between batches)
Solubility
DMSO:50 mg/mL (114.32 mM)
Smiles
Cl.Cl.CCOc1ccccc1-n1c (CN2CCNCC2) nc2ccccc2c1=O
Molecular Formula
C21H26Cl2N4O2
Molecular Weight
437.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker) (rYBX1/2430), CF488A conjugate, 0.1mg/mL
Lentiviral mouse Irgq shRNA (UAS) - Lentiviral mouse Irgq shRNA (UAS, GFP) plasmid
Lentiviral mouse Styxl1 shRNA (UAS) - Lentiviral mouse Styxl1 shRNA (UAS) (100)
